Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia.

Y Collette T Prébet A Goubard J Adélaïde R Castellano N Carbuccia S Garnier A Guille C Arnoulet A Charbonier M J Mozziconacci D Birnbaum M Chaffanet N Vey

Blood Cancer J

1] Centre de Recherche en Cancérologie de Marseille (CRCM) Inserm UMR 1068, Institut Paoli-Calmettes, Aix-Marseille Université UM 105, CNRS UMR 7258, Marseille, France [2] Département d'hématologie, Institut Paoli-Calmettes, Aix-Marseille Université UM 105, CNRS UMR 7258, Marseille, France.

Published: March 2015

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382656	PMC
http://dx.doi.org/10.1038/bcj.2015.13	DOI Listing

Publication Analysis

Top Keywords

drug response

response profiling

profiling predict

predict response

response ponatinib

ponatinib patient

patient t19q24q34-associated

t19q24q34-associated b-cell

b-cell acute

acute lymphoblastic

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!